Related Experiment Video

Updated: Mar 23, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
04:30

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

26.5K

Differences in achieving treatment goals with statin use in various regions of Poland--3ST-POL study results

Daniel Śliż1, Krzysztof J Filipiak2, Marek Naruszewicz3

  • 13rd Department of Internal Medicine and Cardiology, Medical University of Warsaw, Poland; Public Health School, Centre of Postgraduate Medical Education, Poland.

Annals of Agricultural and Environmental Medicine : AAEM
|March 24, 2016
PubMed

Insights

Statin treatment for high cholesterol in Poland shows significant regional disparities in effectiveness. The Northeast region achieved the highest rates of target cholesterol levels, unlike the Northwest region.

Area of Science:

  • Cardiology
  • Public Health
  • Pharmacotherapy

Background:

  • Dyslipidemia is a primary risk factor for ischemic heart disease, a leading cause of mortality.
  • Statin therapy is crucial for preventing ischemic heart disease, but its effectiveness in Poland is suboptimal.
  • Understanding regional variations in treatment efficacy is essential for improving patient outcomes.

Purpose of the Study:

  • To assess regional differences in achieving target total cholesterol (TC) and LDL cholesterol levels.
  • To evaluate the efficacy of outpatient statin treatment across different regions of Poland.

Main Methods:

  • A survey was administered to 49,950 patients undergoing statin treatment in Poland in 2008.
  • Poland was divided into four regions: Northeast (NE), Northwest (NW), Southeast (SE), and Southwest (SW).
  • Treatment efficacy was measured by the achievement of target TC and LDL cholesterol levels.

Main Results:

  • Less than 10% of patients achieved target total cholesterol levels.
  • The Northeast region demonstrated the highest rate of achieving target cholesterol levels, while the Northwest region had the lowest.
  • Cardiologists achieved therapeutic goals more successfully than General Practitioners (GPs), with similar regional and specialization correlations for LDL values.

Conclusions:

  • Significant regional variations exist in the effectiveness of statin therapy for managing cholesterol levels in Poland.
  • The Northeast region's superior results may be linked to the economic development of the Masovian province.
  • Addressing regional disparities and optimizing physician specialization can enhance statin therapy outcomes.
Abstract

More Related Videos

Time-resolved Förster Resonance Energy Transfer Assays for Measurement of Endogenous Phosphorylated STAT Proteins in Human Cells07:12

Time-resolved Förster Resonance Energy Transfer Assays for Measurement of Endogenous Phosphorylated STAT Proteins in Human Cells

Published on: September 9, 2021

4.3K
Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis06:59

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis

Published on: August 26, 2025

704

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.8K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
576
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
591
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
545
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors01:28

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
710
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
398